ArticleJournal of translational medicine2022

Combined treatment with inhibitors of ErbB Receptors and Hh signaling pathways is more effective than single treatment in reducing the growth of malignant mesothelioma both in vitro and in vivo.

Roberto Bei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.